Retrospective cohort study evaluates difluprednate drops’ effect on reducing macular edema in patients post-surgery, suggesting improvement in treatment efficacy.
Purpose: To evaluate the efficacy of difluprednate 0.05% in reducing postsurgical inflammatory macular edema. Methods: This retrospective cohort study included 28 patients (33 eyes) who were treated for postsurgical inflammatory cystoid macular edema (CME) between January 2017 and June 2025. [for full text, please go to the a.m. URL]
No takes yet. Share an insight, caveat, or question.
Schmidt et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: